Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Return on Invested Capital (2019)

Historic Return on Invested Capital for Serina Therapeutics (SER) over the last 1 years, with Q4 2019 value amounting to 3.2%.

  • Serina Therapeutics' Return on Invested Capital changed N/A to 3.2% in Q4 2019 from the same period last year, while for Dec 2019 it was 3.2%, marking a year-over-year change of. This contributed to the annual value of 26.39% for FY2020, which is 287000.0% up from last year.
  • Per Serina Therapeutics' latest filing, its Return on Invested Capital stood at 3.2% for Q4 2019.
  • Over the past 5 years, Serina Therapeutics' Return on Invested Capital peaked at 3.2% during Q4 2019, and registered a low of 3.2% during Q4 2019.